A tRNA-derived fragment from Chinese yew suppresses ovarian cancer growth via targeting TRPA1.

Abstract

Drug discovery from plants usually focuses on small molecules rather than such biological macromolecules as RNAs. Although plant transfer RNA (tRNA)-derived fragment (tRF) has been associated with the developmental and defense mechanisms in plants, its regulatory role in mammals remains unclear. By employing a novel reverse small interfering RNA (siRNA) screening strategy, we show that a tRF mimic (antisense derived from the 5' end of tRNAHis(GUG) of Chinese yew) exhibits comparable anti-cancer activity with that of taxol on ovarian cancer A2780 cells, with a 16-fold lower dosage than that of taxol. A dual-luciferase reporter assay revealed that tRF-T11 directly targets the 3' UTR of oncogene TRPA1 mRNA. Furthermore, an Argonaute-RNA immunoprecipitation (AGO-RIP) assay demonstrated that tRF-T11 can interact with AGO2 to suppress TRPA1 via an RNAi pathway. This study uncovers a new role of plant-derived tRFs in regulating endogenous genes. This holds great promise for exploiting novel RNA drugs derived from nature and sheds light on the discovery of unknown molecular targets of therapeutics.

• Authors: Kai-Yue Cao, Tong-Meng Yan, Ji-Zhou Zhang, Ting-Fung Chan, Jie Li, Chong Li, Elaine Lai-Han Leung, Jin Gao, Bao-Xian Zhang, Zhi-Hong Jiang
• Journal: Molecular therapy. Nucleic acids (Mol Ther Nucleic Acids) Vol. 27 Pg. 718-732 (Mar 08 2022) ISSN: 2162-2531 [Print] United States
• PMID: 35317282 (Publication Type: Journal Article)
• Copyright: © 2022 The Author(s).